Testing Lutathera for meningioma that keeps growing after radiation
Original title: Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage study, so the drug is still being tested in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests a drug called Lutathera in people whose meningioma kept growing after radiation.
Who this trial is for. This trial is for people with meningioma that surgery cannot remove. Their tumor kept growing or spreading after radiation to the head. It tests Lutathera, a radioactive drug given through a vein that is made to find and kill tumor cells.
Where it stands. The trial has not reported results. It is looking at how safe the drug is and how well it works in these tumors. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: Someone in this spot has few clear options left. If this sounds like you, you could ask your care team about it. They know your case and can tell you if it is worth looking into.
What it doesn't mean: This does not mean the drug works. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you. It is not a cure.
Source: ClinicalTrials.gov, October 13, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.